Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian Patients

CompletedOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 4, 2017

Primary Completion Date

March 3, 2018

Study Completion Date

March 3, 2018

Conditions
Type 2 Diabetes
Trial Locations (29)

Unknown

Research Site, Hyderabad

Research Site, Nellor

Research Site, Vijayawada

Research Site, Raipur

Research Site, Ahmedabad

Research Site, Rajkot

Research Site, Surat

Research Site, Bangalore

Research Site, Aurangabad

Research Site, Mumbai

Research Site, Nagpur

Research Site, Pune

Research Site, New Delhi

Research Site, Amritsar

Research Site, Bhathinda

Research Site, Chandigarh

Research Site, Ludhiana

Research Site, Patiāla

Research Site, Jaipur

Research Site, Chennai

Research Site, Coimbatore

Research Site, Madurai

Research Site, Pudhucherry

Research Site, Salem

Research Site, Hyderabad

Research Site, Kanpur

Research Site, Lucknow

Research Site, Jalpāiguri

Research Site, Kolkata

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY